Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.

Forootan FS, Forootan SS, Gou X, Yang J, Liu B, Chen D, Al Fayi MS, Al-Jameel W, Rudland PS, Hussain SA, Ke Y.

Oncotarget. 2016 Feb 23;7(8):9322-39. doi: 10.18632/oncotarget.6975.

2.

Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.

Al-Jameel W, Gou X, Forootan SS, Al Fayi MS, Rudland PS, Forootan FS, Zhang J, Cornford PA, Hussain SA, Ke Y.

Oncotarget. 2017 May 9;8(19):31041-31056. doi: 10.18632/oncotarget.16055.

3.

The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis.

Kawaguchi K, Kinameri A, Suzuki S, Senga S, Ke Y, Fujii H.

Biochem J. 2016 Feb 15;473(4):449-61. doi: 10.1042/BJ20150926. Epub 2015 Nov 27.

PMID:
26614767
4.

Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site.

Eisermann K, Broderick CJ, Bazarov A, Moazam MM, Fraizer GC.

Mol Cancer. 2013 Feb 1;12:7. doi: 10.1186/1476-4598-12-7.

5.

Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts.

Forootan SS, Bao ZZ, Forootan FS, Kamalian L, Zhang Y, Bee A, Foster CS, Ke Y.

Int J Oncol. 2010 Jan;36(1):69-76.

PMID:
19956834
6.

Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.

Tang Q, Wu J, Zheng F, Hann SS, Chen Y.

Cell Physiol Biochem. 2017;41(1):339-357. doi: 10.1159/000456281. Epub 2017 Jan 26. Erratum in: Cell Physiol Biochem. 2017;41(3):1270.

7.

PPAR gamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis.

Peeters LL, Vigne JL, Tee MK, Zhao D, Waite LL, Taylor RN.

Angiogenesis. 2005;8(4):373-9. Epub 2006 Jan 7.

PMID:
16400517
8.

Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.

Fang LY, Wong TY, Chiang WF, Chen YL.

J Oral Pathol Med. 2010 Apr;39(4):342-8. doi: 10.1111/j.1600-0714.2009.00836.x. Epub 2009 Dec 15.

PMID:
20040021
9.

RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.

Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y.

Eur J Cancer. 2011 Oct;47(15):2353-63. doi: 10.1016/j.ejca.2011.05.006. Epub 2011 Jun 15.

PMID:
21680174
10.

Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.

Riddell JR, Maier P, Sass SN, Moser MT, Foster BA, Gollnick SO.

PLoS One. 2012;7(11):e50394. doi: 10.1371/journal.pone.0050394. Epub 2012 Nov 21.

12.

TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.

Takayama K, Horie-Inoue K, Suzuki T, Urano T, Ikeda K, Fujimura T, Takahashi S, Homma Y, Ouchi Y, Inoue S.

Mol Endocrinol. 2012 May;26(5):748-61. doi: 10.1210/me.2011-1242. Epub 2012 Mar 28.

13.

Peroxisome proliferator-activated receptor-γ in capillary endothelia promotes fatty acid uptake by heart during long-term fasting.

Goto K, Iso T, Hanaoka H, Yamaguchi A, Suga T, Hattori A, Irie Y, Shinagawa Y, Matsui H, Syamsunarno MR, Matsui M, Haque A, Arai M, Kunimoto F, Yokoyama T, Endo K, Gonzalez FJ, Kurabayashi M.

J Am Heart Assoc. 2013 Jan 18;2(1):e004861. doi: 10.1161/JAHA.112.004861.

14.

Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer.

Wang N, Zhan T, Ke T, Huang X, Ke D, Wang Q, Li H.

Br J Cancer. 2014 Feb 18;110(4):1034-44. doi: 10.1038/bjc.2013.817. Epub 2014 Jan 14.

15.

PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.

Scoditti E, Massaro M, Carluccio MA, Distante A, Storelli C, De Caterina R.

Cardiovasc Res. 2010 May 1;86(2):302-10. doi: 10.1093/cvr/cvp400. Epub 2009 Dec 23.

PMID:
20032081
16.

Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.

Dondoo TO, Fukumori T, Daizumoto K, Fukawa T, Kohzuki M, Kowada M, Kusuhara Y, Mori H, Nakatsuji H, Takahashi M, Kanayama HO.

Anticancer Res. 2017 Jan;37(1):125-134.

PMID:
28011482
17.

Bradykinin promotes vascular endothelial growth factor expression and increases angiogenesis in human prostate cancer cells.

Yu HS, Wang SW, Chang AC, Tai HC, Yeh HI, Lin YM, Tang CH.

Biochem Pharmacol. 2014 Jan 15;87(2):243-53. doi: 10.1016/j.bcp.2013.10.016. Epub 2013 Nov 10.

PMID:
24225154
18.

The Contribution of EDF1 to PPARγ Transcriptional Activation in VEGF-Treated Human Endothelial Cells.

Cazzaniga A, Locatelli L, Castiglioni S, Maier J.

Int J Mol Sci. 2018 Jun 21;19(7). pii: E1830. doi: 10.3390/ijms19071830.

19.
20.

Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells.

Ruiz M, Pettaway C, Song R, Stoeltzing O, Ellis L, Bar-Eli M.

Cancer Res. 2004 Jan 15;64(2):631-8.

Supplemental Content

Support Center